Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 26, 2022 at 9:00am EDT
May 12 2022 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that its
2022 Annual Meeting of Stockholders will be held in a virtual-only
format via live audio webcast on Thursday, May 26, 2022 at 9:00 AM
EDT.
HOW TO PARTICIPATE IN THE VIRTUAL ANNUAL
MEETINGAs described in the proxy materials, stockholders
of record are eligible to participate in and ask questions during
the Virtual Annual Meeting by visiting
www.virtualshareholdermeeting.com/EBS2022 and entering their
16-digit Control Number provided on the proxy card, voting
instruction form or notice received from the Company to log into
this website. Only one stockholder per 16-digit Control Number can
access the Virtual Annual Meeting.
Beneficial owners of shares held in street name will need to
follow the instructions provided by the broker, bank or other
nominee that holds their shares.
Those without a Control Number may attend as guests in
listen-only mode and will not have the option to vote their shares
or ask questions during the Virtual Annual Meeting.
ALL PARTICIPANTS ARE ENCOURAGED TO LOG IN AND ACCESS THE
WEBCAST 15 MINUTES BEFORE THE VIRTUAL ANNUAL MEETING
BEGINS.
Further instructions on how to attend, participate in and vote
at the Virtual Annual Meeting, including how to demonstrate your
ownership of the Company’s common stock as of the record date, are
available at www.virtualshareholdermeeting.com/EBS2022.
A replay of the audio webcast will be made available on the
Emergent website.
About Emergent BioSolutionsAt Emergent, our
mission is to protect and enhance life. For over 20 years, we’ve
been at work defending people from things we hope will never
happen—so we are prepared just in case they ever do. We provide
solutions for complex and urgent public health threats through a
portfolio of vaccines and therapeutics that we develop and
manufacture for governments and consumers. We also offer a range of
integrated contract development and manufacturing services for
pharmaceutical and biotechnology customers. To learn more about how
we plan to protect or enhance 1 billion lives by 2030, visit our
website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Matt HartwigSenior
Director, Media Relationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024